Here is the plain text version of the feed:
Vivek Ramaswamy is the less famous and less wealthy half of the duo of billionaires that President-elect Donald J. Trump has designated to slash government costs.
His better-known co-leader, Elon Musk, stands to benefit from the job in ways that are numerous and glaring.
Less attention has been paid to the potential conflicts that could stem from Mr. Ramaswamy’s complex web of financial interests, which span biotechnology, finance, and other holdings.
At 39, he is one of the world’s youngest billionaires, having made his fortune in the pharmaceutical industry.
Mr. Ramaswamy, who owns a stake valued at nearly $600 million in a biotechnology company he started, has called for changes at the Food and Drug Administration that would speed up drug approvals.
He founded his biotechnology company, Roivant Sciences, in 2014, betting that he could find hidden gems whose potential had been overlooked by large drugmakers.
…
…
The rest of the content is the same, without modification.
Source link
